TOLLIP and idiopathic pulmonary fibrosis: Post-hoc analysis in the PANTHER-IPF trial showed that rs3750920 (TOLLIP) TT genotype affected positively the response to N-acetylcysteine (NAC) providing evidence that in a precision-medicine era, genotype-stratified prospective clinical trials should be conducted before any recommendation for therapeutic options in IPF [251].